NASDAQ: BNKKBonk Inc Stock
$0.39-0.03 (-7.14%)
Updated Oct 9, 2025
BNKK Price
$0.39
Fair Value Price
N/A
Market Cap
$56.79M
52 Week Low
$0.23
52 Week High
$1.34
P/E
-1.12x
P/B
2.46x
P/S
72.35x
PEG
N/A
Dividend Yield
N/A
Revenue
$379.44k
Earnings
-$17.41M
Gross Margin
-174.9%
Operating Margin
-4,532.65%
Profit Margin
-5,193.5%
Debt to Equity
0.82
Operating Cash Flow
-$12M
Beta
0.83
Next Earnings
Dec 3, 2025
Ex-Dividend
N/A
Next Dividend
N/A
BNKK Overview
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. It also manufactures consumer products such as CBD-infused sunscreen under the CaniSun brand, CBD-infused skin care lotion under the CaniSkin brand, and products for dermatological treatment of pain and inflammation under the CaniDermRX brand. Jupiter Wellness was incorporated in 2018 and is headquartered in Jupiter, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BNKK's potential to beat the market
- BNKK doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Beverage
Industry Rating
B
BNKK
RankedUnranked of 15
RankedUnranked of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $124.48 | B | |
| $69.62 | C | |
| $150.08 | C |
Be the first to know about important BNKK news, forecast changes, insider trades & much more!
BNKK News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BNKK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BNKK is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BNKK is good value based on its book value relative to its share price (2.46x), compared to the US Beverages - Non-Alcoholic industry average (6.78x)
P/B vs Industry Valuation
BNKK is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BNKK due diligence checks available for Premium users.
Valuation
BNKK fair value
Fair Value of BNKK stock based on Discounted Cash Flow (DCF)
Price
$0.39
Fair Value
-$1.04
Undervalued by
137.41%
BNKK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BNKK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.12x
Industry
28.59x
Market
35.9x
BNKK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.46x
Industry
6.78x
BNKK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BNKK's financial health
Profit margin
Revenue
$44.9k
Net Income
$13.4M
Profit Margin
29,756.5%
BNKK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BNKK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$42.1M
Liabilities
$19.0M
Debt to equity
0.82
BNKK's short-term assets ($21.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BNKK's short-term assets ($21.94M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BNKK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BNKK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.7M
Investing
$120.6k
Financing
$1.7M
BNKK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BNKK vs Beverage Stocks
Bonk Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.